First-in-Human Study of the GDF-15 Neutralizing Antibody Visugromab (CTL-002) in Patients With Advanced Cancer (GDFATHER)
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Sujata Rao, MD
CatylYm GmbH
Study Director
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
13 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Universitätsklinikum Essen, Westdeutsches Tumorzentrum, Innere Klinik Und Poliklinik
Essen, Germany
- Universitätsklinikum Frankfurt, Medizinische Klinik I
Frankfurt am Main, Germany
- Universitätsklinikum Würzburg, Comprehensive Cancer Center
Würzburg, Germany
- Hospital Universitari Vall D'Hebron, Institute of Oncology
Barcelona, Spain
- Icmdim, Hospital Clinic
Barcelona, Spain
- Ico Hospitalet, Hospital Duran I Reynals
Barcelona, Spain
- Next Oncology, Phase I Unit. Iob - Hospital Quironsalud
Barcelona, Spain
- Hospital Universitario 12 de Octubre
Madrid, Spain
- Start Madrid, Hospital Universitario Hm Sanchinarro
Madrid, Spain
- Clinica Universidad de Navarra, Unidad Central de Ensayos Clinicos
Pamplona, Spain
- University Hospital Basel, Department for Medical Oncology
Basel, Switzerland
- Kantonsspital St. Gallen, Clinic for Medical Oncology & Hematology
Sankt Gallen, Switzerland
- University Hospital Zurich, Department of Dermatology
Zurich, Switzerland
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 9 Dec 2020
- Primary completion
- 30 Apr 2028
- Completion
- 30 Apr 2030
- Last update posted
- 12 Jan 2026
- Registered enrollment
- 263
- Registry id
- NCT04725474
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.